Literature DB >> 16365184

A role for p38 mitogen-activated protein kinase and c-myc in endothelin-dependent rat aortic smooth muscle cell proliferation.

Songcang Chen1, Ye Qiong, David G Gardner.   

Abstract

We have demonstrated recently that endothelin (ET) stimulates rat aortic smooth muscle cell proliferation through an extracellular signal-regulated kinase (ERK)-dependent mechanism. Approximately 70% of ET-dependent [3H]-thymidine incorporation in these cells signals through this system. In the present study, we show that the residual mitogenic activity requires an intact p38 mitogen-activated protein kinase (p38 MAPK) system and increased c-myc gene expression. ET increased [3H]-thymidine incorporation in rat aortic smooth muscle cells approximately 5-fold. p38 MAPK inhibition with SB203580 or ERK/ERK kinase inhibition with PD98059 each effected approximately 70% inhibition in ET-dependent DNA synthesis, whereas the combination led to nearly complete blockade of the ET effect. ET also increased c-myc RNA levels and c-Myc protein levels in these cells. The increment in c-Myc expression was blocked by SB203580 but not by PD98059. Use of antisense oligonucleotides directed against the translation start site of the c-myc transcript, but not scrambled oligonucleotide sequence, resulted in approximately 60% decrease in ET-dependent [3H]-thymidine incorporation. The combination of antisense c-myc and PD98059 resulted in near complete inhibition of ET-dependent DNA synthesis. Both ET and c-Myc increased expression and promoter activity of E2F, a transcription factor that has been linked to enhanced cell cycle activity. The ET-dependent increment in E2F promoter activity was suppressed after treatment with SB203580 or antisense c-myc but not by PD98059 or a scrambled oligonucleotide sequence. Collectively, these findings demonstrate that ET uses 2 complementary signal transduction cascades (ERK and p38 MAPK) to control proliferative activity of vascular smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16365184     DOI: 10.1161/01.HYP.0000198424.93598.6b

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

1.  Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stress.

Authors:  Talin Ebrahimian; Melissa Wei Li; Catherine A Lemarié; Stefania M C Simeone; Patrick J Pagano; Matthias Gaestel; Pierre Paradis; Sven Wassmann; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2010-12-20       Impact factor: 10.190

Review 2.  The Role of TGF-β Signaling in Cardiomyocyte Proliferation.

Authors:  Daniel W Sorensen; Jop H van Berlo
Journal:  Curr Heart Fail Rep       Date:  2020-10

3.  Differential regulation of pericyte function by the CXC receptor 3.

Authors:  Richard J Bodnar; Alan Wells
Journal:  Wound Repair Regen       Date:  2015-10-19       Impact factor: 3.617

4.  Requirement for p38 mitogen-activated protein kinase activity in neointima formation after vascular injury.

Authors:  Brandon M Proctor; Xiaohua Jin; Traian S Lupu; Louis J Muglia; Clay F Semenkovich; Anthony J Muslin
Journal:  Circulation       Date:  2008-07-21       Impact factor: 29.690

5.  Effects of ouabain on proliferation, intracellular free calcium and c-myc mRNA expression in vascular smooth muscle cells.

Authors:  Mengquan Li; Qiujuan Wang; Lixin Guan
Journal:  J Comp Physiol B       Date:  2007-04-13       Impact factor: 2.230

6.  Targeting TRAF3 Downstream Signaling Pathways in B cell Neoplasms.

Authors:  Carissa R Moore; Shanique Ke Edwards; Ping Xie
Journal:  J Cancer Sci Ther       Date:  2015-02

7.  The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats.

Authors:  Jie Li; Li Peng; Hong Du; Yangtian Wang; Bin Lu; Yixin Xu; Xiaozhen Ye; Jiaqing Shao
Journal:  Int J Endocrinol       Date:  2014-11-11       Impact factor: 3.257

8.  An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers.

Authors:  Mélanie Mahe; Florent Dufour; Hélène Neyret-Kahn; Aura Moreno-Vega; Claire Beraud; Mingjun Shi; Imene Hamaidi; Virginia Sanchez-Quiles; Clementine Krucker; Marion Dorland-Galliot; Elodie Chapeaublanc; Remy Nicolle; Hervé Lang; Celio Pouponnot; Thierry Massfelder; François Radvanyi; Isabelle Bernard-Pierrot
Journal:  EMBO Mol Med       Date:  2018-04       Impact factor: 12.137

9.  N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma.

Authors:  Shanique K E Edwards; Carissa R Moore; Yan Liu; Sukhdeep Grewal; Lori R Covey; Ping Xie
Journal:  BMC Cancer       Date:  2013-10-16       Impact factor: 4.430

10.  Integrating genomics and proteomics data to predict drug effects using binary linear programming.

Authors:  Zhiwei Ji; Jing Su; Chenglin Liu; Hongyan Wang; Deshuang Huang; Xiaobo Zhou
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.